Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21301194 | 0.90 | LMNA (0.44) | LMNAPOLB | |
| SCHEMBL17830438 | 0.90 | LPAR1 (0.52) | NLRP3LPAR1LPAR3ENPP2 | |
| SCHEMBL12920227 | 0.90 | LPAR1 (0.52) | NLRP3LPAR1LPAR3ENPP2 | |
| SCHEMBL17830332 | 0.90 | LPAR1 (0.52) | NLRP3LPAR1LPAR3ENPP2 | |
| SCHEMBL14003899 | 0.89 | LMNA (0.46) | NLRP3LPAR1LPAR3LMNAPOLB | |
| SCHEMBL13217160 | 0.89 | LMNA (0.50) | LPAR1LMNAPOLB | |
| SCHEMBL30114611 | 0.87 | L3MBTL1 (0.35) | LPAR1LPAR3LMNAPOLB | |
| SCHEMBL8157771 | 0.87 | L3MBTL1 (0.35) | LPAR1LPAR3LMNAPOLB | |
| SCHEMBL17227788 | 0.87 | MGLL (0.46) | NLRP3LPAR1LPAR3LMNAPOLB | |
| SCHEMBL13599890 | 0.84 | ALDH1A1 (0.51) | LPAR1LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3670618-B1 | METHOD FOR PRODUCING FUNCTIONALIZED POLYESTERS | HENKEL AG & CO KGAA (DE) | 2023-05-03 | — | — | EP | disclosed |
| US-20200056038-A1 | POLY (ALKYL CARBONATE) ADHESIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2020-02-20 | — | — | US | disclosed |
| WO-2014119698-A1 | PATTERN FORMING METHOD, COMPOUND USED THEREIN, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, MANUFACTURING METHOD OF ELECTRONIC DEVICE, AND ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2014-08-07 | — | — | WO | disclosed |
| US-20080255373-A1 | PROCESS FOR THE PRODUCTION OF GLYCEROL CARBONATE ESTERS | COGNIS OLEOCHEMICALS GMBH (DE) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255373-A1 | PROCESS FOR THE PRODUCTION OF GLYCEROL CARBONATE ESTERS | GK, HSD11B1, DGAT2 | NLRP3 3571/4885LPAR1 902/4885LPAR3 345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.